Efficacy of Hydrogen Peroxide ( H2O2) in Controlling Placental Site Bleeding in Caesarian Delivery for Placenta Previa / Accreta Spectrum ( PAS)

Sponsor
Cairo University (Other)
Overall Status
Recruiting
CT.gov ID
NCT06030492
Collaborator
(none)
84
1
2
9.4
8.9

Study Details

Study Description

Brief Summary

Placenta accreta spectrum (PAS), encompassing the terms placenta accreta, increta, and percreta; abnormally invasive placenta; morbidly adherent placenta; and invasive placentation, is a leading cause of life-threatening obstetric haemorrage (1) . Currently, more than 90% of women diagnosed with PAS also have a placenta praevia (2), and the combination of both conditions leads to high maternal morbidity and mortality due to massive haemorrhage at the time of birth . Maternal mortality of placenta praevia with percreta has been reported to be as high as 7% of cases .

Hydrogen peroxide is well-known for its antimicrobial and antiseptic properties. It is used to clean surgical cuts for better localization of bleeding focus in surgery and orthopedics and burn excisions to induce hemostasis . Topical application of hydrogen peroxide was proven to induce hemostasis and reduce operative time in both tonsillectomy and adenoidectomy .

Condition or Disease Intervention/Treatment Phase
  • Drug: packing placental site with hydrogen peroxide soaked towels
  • Drug: normal Saline
N/A

Detailed Description

  • Population of study: A total of 84 pregnant patients with placenta previa / Accreta spectrum.

  • Study location: Obstetrics and Gynecology Kasr Al-Ainy Hospital , Faculty of Medicine , Cairo University.

The aim of the study is to evaluate the efficacy of hydrogen peroxide for controlling bleeding from placental bed in caesarian section for placenta previa/ Accreta spectrum (PAS).

• This is a randomized controlled trial including a total number of 84 patients representing study group , randomized in 2 equal groups , using computer generated randomization sheet on (Medcalc ®) .

Group A : hydrogen peroxide group (n=42)

Group B : control group (normal Saline solution) (n=42) .

Study Design

Study Type:
Interventional
Anticipated Enrollment :
84 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Care Provider, Investigator)
Primary Purpose:
Treatment
Official Title:
Efficacy of Hydrogen Peroxide ( H2O2) in Controlling Placental Site Bleeding in Caesarian Delivery for Placenta Previa / Accreta Spectrum ( PAS)
Actual Study Start Date :
Jan 1, 2023
Anticipated Primary Completion Date :
Sep 30, 2023
Anticipated Study Completion Date :
Oct 15, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: hydrogen peroxide group

hydrogen peroxide group Irrigation of the placental bed with 100 ml 3% hydrogen peroxide , followed by packing with a towel highly soaked hydrogen peroxide solution (Pozitif Kimya, İstanbul, Turkey) , freshly prepared by a 50% dilution with a normal saline solution.(

Drug: packing placental site with hydrogen peroxide soaked towels
Skin is incised either midline or Pfannenstiel incision according to clinical situation , bladder dissection will be done , uterus will be incised by transverse lower segment incision , followed by delivery of the baby. Uterine massage , ecbolics & a trial for delivery of the placenta will be done Irrigation of the placental bed with 100 ml 3% hydrogen peroxide , followed by packing with a towel highly soaked hydrogen peroxide solution (Pozitif Kimya, İstanbul, Turkey) , freshly prepared by a 50% dilution with a normal saline solution

Placebo Comparator: normal Saline solution

Packing the placental bed with a towel soaked with normal Saline solution

Drug: normal Saline
Skin is incised either midline or Pfannenstiel incision according to clinical situation , bladder dissection will be done , uterus will be incised by transverse lower segment incision , followed by delivery of the baby. Uterine massage , ecbolics & a trial for delivery of the placenta will be done. Packing the placental bed with a towel soaked with normal Saline solution

Outcome Measures

Primary Outcome Measures

  1. control of intra-operative bleeding from placental bed [3 minutes after application of topical drug , identified as arrest of bleeding or minimal oozing from placental bed with good general condition & no hemoglobin drop]

    control of intra-operative bleeding from placental bed

Secondary Outcome Measures

  1. Estimated intraoperative blood loss [from begining to end of surgery]

    Estimated intraoperative blood loss by towel saturarion , amount of blood in suction , and pre& postoperative hemoglobin and hematocrite

  2. Need for hemostatic sutures , uterine artery ligation , internal iliac artery ligation , hysterectomy [3 minutes after topical application , if bleeding continued]

    Need for hemostatic sutures , uterine artery ligation , internal iliac artery ligation , hysterectomy

  3. immediate maternal complications ( postpartum haemorrage , DIC , hysterectomy , maternal mortality , ICU admission , …) [within 1st 24 hours postoperative]

    immediate maternal complications ( postpartum haemorrage , DIC , hysterectomy , maternal mortality , ICU admission , …)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 40 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Age from 18-40 years

  • BMI < 35 kg/m2

  • Pregnant patients with placenta previa .

  • Placenta accrete FIGO grade 1 .

  • Vitally stable .

  • Candidate for conservative management.

  • No major intra-operative bleeding.

Exclusion Criteria:
  • Vitally unstable .

  • Massive pre- or intra-operative bleeding.

  • Medical disorders ( e.g. : hypertension , cardiac …. )

  • Placenta accrete , FIGO grades 2 or 3 .

  • Not indicated for conservative management.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Kasr Alainy outpatient infertility clinic Cairo Egypt

Sponsors and Collaborators

  • Cairo University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Bassiony Dabian, lecturer of obstetrics and gynecology, Cairo University
ClinicalTrials.gov Identifier:
NCT06030492
Other Study ID Numbers:
  • MS-467-2023
First Posted:
Sep 11, 2023
Last Update Posted:
Sep 11, 2023
Last Verified:
Sep 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 11, 2023